These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8791110)
1. Methodological issues in the design of primary prevention trials. Gaziano JM; Hennekens CH; Buring JE IARC Sci Publ; 1996; (136):7-12. PubMed ID: 8791110 [No Abstract] [Full Text] [Related]
2. Why did antioxidants not protect against lung cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study? Huttunen JK IARC Sci Publ; 1996; (136):63-5. PubMed ID: 8791117 [No Abstract] [Full Text] [Related]
3. Evaluation of human trial findings. Huttunen JK IARC Sci Publ; 1996; (139):271-6. PubMed ID: 8923037 [TBL] [Abstract][Full Text] [Related]
4. An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention. Kim ES; Hong WK J Natl Cancer Inst; 2005 Apr; 97(7):468-70. PubMed ID: 15812064 [No Abstract] [Full Text] [Related]
5. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future. Omenn GS Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088 [TBL] [Abstract][Full Text] [Related]
6. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer. Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451 [TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers. Omenn GS; Goodman G; Thornquist M; Barnhart S; Balmes J; Cherniack M; Cullen M; Glass A; Keogh J; Liu D; Meyskens F; Perloff M; Valanis B; Williams J IARC Sci Publ; 1996; (136):67-85. PubMed ID: 8791118 [No Abstract] [Full Text] [Related]
8. Ethical issues of intervention trials in cancer. Sancho-Garnier H; Joseph R IARC Sci Publ; 1996; (136):121-2. PubMed ID: 8791122 [No Abstract] [Full Text] [Related]
9. Systemic chemoprevention. Shumack S Cancer Treat Res; 2009; 146():461-6. PubMed ID: 19415225 [No Abstract] [Full Text] [Related]
10. Evaluation of human trial design. Buiatti E IARC Sci Publ; 1996; (139):261-9. PubMed ID: 8923036 [TBL] [Abstract][Full Text] [Related]
11. The role of chemoprevention in cancer control. Greenwald P; Kelloff GJ IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016 [TBL] [Abstract][Full Text] [Related]
12. beta-Carotene and the prevention of cancer. Vilenchik MM Science; 1994 Oct; 266(5182):14-5. PubMed ID: 7939634 [No Abstract] [Full Text] [Related]
13. [Results of the NSABP clinical trial for the prevention of cancer of the breast]. Namer M Bull Cancer; 1998 Apr; 85(4):299. PubMed ID: 9752291 [No Abstract] [Full Text] [Related]
14. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials. Greenwald P J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595 [TBL] [Abstract][Full Text] [Related]
15. Cancer prevention I: introduction. Dunn BK; Greenwald P Semin Oncol; 2010 Jun; 37(3):190-201. PubMed ID: 20709204 [No Abstract] [Full Text] [Related]
16. Current issues in cancer chemoprevention. Buring JE; Hennekens CH IARC Sci Publ; 1990; (103):185-93. PubMed ID: 2279796 [No Abstract] [Full Text] [Related]
17. Twenty years and counting. Hartness S J Miss State Med Assoc; 2003 Mar; 44(3):84-5. PubMed ID: 12744147 [No Abstract] [Full Text] [Related]